CHROMOGENICS AB

The current price of CHRO is 7.22 SEK — it has increased by 1.98% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange CHROMOGENICS AB stocks are traded under the ticker CHRO.

CHRO stock is 2.85% volatile and has beta coefficient of −1.94. Check out the list of the most volatile stocks — is CHROMOGENICS AB there?

Yes, you can track CHROMOGENICS AB financials in yearly and quarterly reports right on TradingView.

CHRO stock has fallen by 1.10% compared to the previous week, the month change is a 9.73% rise, over the last year CHROMOGENICS AB has showed a 65.45% decrease.

CHRO net income for the last quarter is ‪−16.60 M‬ SEK, while the quarter before that showed ‪−10.96 M‬ SEK of net income which accounts for −51.46% change. Track more CHROMOGENICS AB financial stats to get the full picture.

No, CHRO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, CHRO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CHROMOGENICS AB stock right from TradingView charts — choose your broker and connect to your account.

CHRO reached its all-time high on Mar 23, 2017 with the price of 38274.42 SEK, and its all-time low was 3.86 SEK and was reached on Dec 5, 2023.
See other stocks reaching their highest and lowest prices.

As of Apr 19, 2024, the company has 33.00 employees. See our rating of the largest employees — is CHROMOGENICS AB on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CHROMOGENICS AB technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CHROMOGENICS AB stock shows the sell signal. See more of CHROMOGENICS AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CHROMOGENICS AB EBITDA is ‪−46.16 M‬ SEK, and current EBITDA margin is −338.29%. See more stats in CHROMOGENICS AB financial statements.